Juniper Publishers | Journal of Gynecology and Women’s Health
Standard and Novel Therapies in Endometrial Cancer--Journal of Gynecology and Women’s Health-Juniper Publishers
JUNIPER PUBLISHERS- JOURNAL OF GYNECOLOGY AND WOMEN’S
HEALTH
STANDARD AND NOVEL THERAPIES IN ENDOMETRIAL CANCER
In developed countries, endometrial cancer (EC) represents the most
common malignancy of the female genital tract. Especially in the
United States, the average life time risk for EC is about 2.64%. EC
usually affects postmenopausal women and the most common presenting
symptom is abnormal uterine bleeding. Based on the clinical and
pathological features, sporadic EC classified into 2 different types
(type I EC and type II EC). Type I EC, represents the majority of
sporadic EC cases (70-80%), is usually well differentiated and
endometrioid in histology Type II EC, represents the minority of
sporadic EC cases (10-20%), is poorly differentiated and usually
papillary serous or clear cell in histology. The classification of
sporadic EC plays an essential role for the entire management of the
disease.
For more articles on Gynecology and Women’s
Health please click on:
https://juniperpublishers.com/jgwh/
Comments
Post a Comment